Revolution Medicines, Inc. (RVMDW)
Nasdaq: RVMDW · CIK 0001628171 · United States
Every official Revolution Medicines, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open RVMDW filings
Revolution Medicines, Inc. documents
- Revolution Medicines, Inc. 10-K 2026RVMDW 10-K 2026: annual report for fiscal 2026
- Revolution Medicines, Inc. 10-K 2025RVMDW 10-K 2025: annual report for fiscal 2025
- Revolution Medicines, Inc. 10-K 2024RVMDW 10-K 2024: annual report for fiscal 2024
- Revolution Medicines, Inc. 10-K 2023RVMDW 10-K 2023: annual report for fiscal 2023
- Revolution Medicines, Inc. 10-K 2022RVMDW 10-K 2022: annual report for fiscal 2022
- Revolution Medicines, Inc. 10-Q 2026RVMDW 10-Q 2026: quarterly report for fiscal 2026
- Revolution Medicines, Inc. 10-Q 2025RVMDW 10-Q 2025: quarterly report for fiscal 2025
- Revolution Medicines, Inc. 10-Q 2024RVMDW 10-Q 2024: quarterly report for fiscal 2024
- Revolution Medicines, Inc. 10-Q 2023RVMDW 10-Q 2023: quarterly report for fiscal 2023
- Revolution Medicines, Inc. 10-Q 2022RVMDW 10-Q 2022: quarterly report for fiscal 2022
- Revolution Medicines, Inc. 8-K 2026RVMDW 8-K 2026: current report for fiscal 2026
- Revolution Medicines, Inc. 8-K 2025RVMDW 8-K 2025: current report for fiscal 2025
- Revolution Medicines, Inc. 8-K 2024RVMDW 8-K 2024: current report for fiscal 2024
- Revolution Medicines, Inc. 8-K 2023RVMDW 8-K 2023: current report for fiscal 2023
- Revolution Medicines, Inc. 8-K 2022RVMDW 8-K 2022: current report for fiscal 2022
- Revolution Medicines, Inc. DEF 14A 2026RVMDW DEF 14A 2026: proxy statement for fiscal 2026
- Revolution Medicines, Inc. DEF 14A 2025RVMDW DEF 14A 2025: proxy statement for fiscal 2025
- Revolution Medicines, Inc. DEF 14A 2024RVMDW DEF 14A 2024: proxy statement for fiscal 2024
- Revolution Medicines, Inc. DEF 14A 2023RVMDW DEF 14A 2023: proxy statement for fiscal 2023
- Revolution Medicines, Inc. DEF 14A 2022RVMDW DEF 14A 2022: proxy statement for fiscal 2022
- Revolution Medicines, Inc. Form 4 2026RVMDW Form 4 2026: insider trading filing for fiscal 2026
- Revolution Medicines, Inc. Form 4 2025RVMDW Form 4 2025: insider trading filing for fiscal 2025
- Revolution Medicines, Inc. Form 4 2024RVMDW Form 4 2024: insider trading filing for fiscal 2024
- Revolution Medicines, Inc. Form 4 2023RVMDW Form 4 2023: insider trading filing for fiscal 2023
- Revolution Medicines, Inc. Form 4 2022RVMDW Form 4 2022: insider trading filing for fiscal 2022
- Revolution Medicines, Inc. S-1 2026RVMDW S-1 2026: registration statement for fiscal 2026
- Revolution Medicines, Inc. S-1 2025RVMDW S-1 2025: registration statement for fiscal 2025
- Revolution Medicines, Inc. S-1 2024RVMDW S-1 2024: registration statement for fiscal 2024
- Revolution Medicines, Inc. S-1 2023RVMDW S-1 2023: registration statement for fiscal 2023
- Revolution Medicines, Inc. S-1 2022RVMDW S-1 2022: registration statement for fiscal 2022
- Revolution Medicines, Inc. 13F 2026RVMDW 13F 2026: institutional holdings for fiscal 2026
- Revolution Medicines, Inc. 13F 2025RVMDW 13F 2025: institutional holdings for fiscal 2025
- Revolution Medicines, Inc. 13F 2024RVMDW 13F 2024: institutional holdings for fiscal 2024
- Revolution Medicines, Inc. 13F 2023RVMDW 13F 2023: institutional holdings for fiscal 2023
- Revolution Medicines, Inc. 13F 2022RVMDW 13F 2022: institutional holdings for fiscal 2022
More companies